Ontramab 150mg Injection: Innovative Treatment Solution

Uses:

• Advanced and metastatic breast cancer;
• Metastatic gastric cancer with increased levels of HER2 proteins.

Mechanism of action:

• Ontramab 150mg Injection contains Trastuzumab as an active constituent.
• It selectively binds to HER2 proteins, which are overexpressed in certain breast cancer cells.
• This binding stops the growth of cancer cells.

Important information:

• Not recommended for patients under 18 years of age.
• Contraindicated for patients with severe breathing problems or those requiring oxygen treatment.
• Inform your physician about any heart problems, breathlessness, or previous cancer treatment.
• Inform your physician about all medications, including supplements and herbal medicines, before starting treatment.

Administration:

• Administered intravenously.
• Initial infusion duration is 90 minutes; subsequent infusions can be administered within 30 minutes if well tolerated.

Safety advice:

• Pregnancy: Discuss with your physician before taking this medication if you are pregnant or think you might be pregnant.
• Breastfeeding: Avoid breastfeeding while on treatment and for at least seven months after the final dose.
• Lungs: Consult your doctor if you have any lung conditions before starting treatment.
• Liver: Inform your physician of any liver disorders before starting treatment, as dosage adjustment may be necessary.
• Alcohol: Consult your doctor to know if it is safe to consume alcohol while on treatment.
• Driving: Avoid driving or handling machinery during treatment due to potential side effects such as dizziness and fatigue.

Side effects:

• Serious: Heart problems, allergic reactions, kidney problems, breathing difficulties.
• Common: Fever, visual disturbances, nose bleeds or runny nose, hair loss, dizziness, nail disorders, weight loss, loss of appetite, bruising, dry mouth, liver inflammation, muscle pain, asthma/lung disorders.

FAQ:

• Q1: Is Ontramab 150mg Injection used as a monotherapy in treating breast cancer?

  • Answer: No, it is generally given along with chemotherapy medications such as paclitaxel or docetaxel or platinum compounds. Sometimes it is also given with hormonal agents for those patients with elevated hormonal status.

• Q2: Does Ontramab 150mg Injection cause heart problems?

  • Answer: Yes, it can damage the heart muscles. Heart check-ups are advised every 3 months and continued for 2-5 years after treatment completion.

• Q3: Can I breastfeed while on treatment with Ontramab 150mg Injection?

  • Answer: No, it is unsafe to breastfeed while on treatment and for at least 7 months after the last dose.

• Q4: Can Ontramab 150mg Injection be consumed during pregnancy?

  • Answer: No, it is unsafe to consume during pregnancy as it can cause harm to the baby. Discuss birth control methods with your physician.

Fact box:

• Molecule name: Trastuzumab.
• Therapeutic class: Anti-cancer.
• Pharmacological class: HER2 inhibitor.
• Indications:
  • Advanced and metastatic breast cancer;
  • Metastatic gastric cancer.

Tags: medical-injection, ontramab, drugs, pharmaceuticals, 150mg